Ticker: AIM

Company: HEMISPHERX BIOPHARMA INC

Person: THOMAS K EQUELS, director, officer

Transaction date: Nov. 20, 2024

Reporting date: Nov. 20, 2024

Average share price: 0.183

Bought 60110.0 shares for 11000.13